findmyKOL
Clinical trialNCT01516567CompletedPhase 2Interventional

Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation

SponsorGustave Roussy, Cancer Campus, Grand ParisEnrollment47Primary Mediastinal Large B Cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • University Hospitals Leuven

    Leuven, Belgium

Canada
  • Children Oncology Group Operations Centres

    Monrovia, Canada

France
  • Gustave Roussy

    Villejuif, France

Hungary
  • 2nd Dept. of Pediatrics Semmelweis Univ.

    Budapest, Hungary

Italy
  • Associazione Italiana Di Ematologia Ed Oncologia Pediatrica

    Padova, Italy

Netherlands
  • Emma Children'S Hospital

    Amsterdam, Netherlands

Poland
  • Rectorat of Medical University

    Wroclaw, Poland

Spain
  • Sociedad Española de Hematología Y Oncología Pediátricas

    Valencia, Spain

United Kingdom
  • University of Birmingham

    Birmingham, United Kingdom

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Apr 2012
Primary completion
30 Apr 2017
Completion
16 Nov 2022
Last update posted
9 Feb 2026
Registered enrollment
47
Registry id
NCT01516567

Cross-registrations

EU-CTR / CTIS (EudraCT)2010-019224-31

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.